Biotech and pharma business news, with a focus on the science, people and money that drive the industry.

Jan 10, 2025 · JPM agenda focuses on Trump 2.0 transition, market recovery & US-China dynamics, featuring talks with Sanofi's Ashrafian, ARCH's Nelsen, Scott Gottlieb & other leaders.

request magic link. If you're already an Endpoints subscriber, enter your email below for a magic link that lets you log in quickly without using a password.Please note the magic link is one-time ...

In the biopharma world, the new year doesn’t start on January 1 — it starts when the industry descends on San Francisco for JPM. Dealmakers, investors, and corporate leaders will gather to chart the course for 2025 and take stock of the landscape, both financial and political.

Life sciences marketers work with long sales cycles and products that require market education — which make webinars one of the most essential tools in the biopharma demand generation toolbox.

Jan 13, 2025 · How a new Washington affects biopharma: In conversation with Scott Gottlieb . Investor, policy expert and former FDA Commissioner Scott Gottlieb will share his insights on how the Trump administration’s new priorities will affect the biopharma industry, in what could be a turbulent time of policy and political changes.

Dec 11, 2024 · We’ve asked our advisory group in the E100 about how things are shaping up at the FDA and HHS under the new Trump administration and what impact prospective changes could have on the drug development industry. Also, they have insights on the tense China-US relations and drug development, AI and our continuing focus on financing at …

Sep 26, 2024 · We’re back with this year’s selection of the top eleven most promising biotechs. They’re taking big swings with cutting-edge science and proven leadership, and the industry is watching to see if they succeed — or fail. Either way, they’ll be bellwethers for where biotech is heading. Join a select group of industry leaders for this year’s awards gala in …

request magic link. If you're already an Endpoints subscriber, enter your email below for a magic link that lets you log in quickly without using a password.Please note the magic link is one-time ...

Dec 21, 2024 · Endpoints Weekly reports newsletter break Dec 24-Jan 2. Highlights: Novo's CagriSema data disappoints, Merck licenses GLP-1 from Hansoh Pharma, and Trump's FTC picks show less pharma focus.